<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Campbell Timm | Activity</title>
	<link>https://www.catswannabecats.com/members/orangemagic7/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/orangemagic7/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Campbell Timm.</description>
	<lastBuildDate>Sat, 04 Jul 2026 08:03:39 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">14811d9b15e34a2bd23eae7d0a70df23</guid>
				<title>Campbell Timm posted an update: Objective Earlier comorbidity measures have been developed [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12317/</link>
				<pubDate>Sun, 01 Jun 2025 09:13:21 -0400</pubDate>

									<content:encoded><![CDATA[<p>Objective Earlier comorbidity measures have been developed or validated using the North American population. This study aims to compare five Charlson or Elixhauser comorbidity indices to predict in-hospital mortality using a large electronic medical record database from Shanxi, China. Methods Using the primary diagnosis code and surgery procedure&hellip;<span class="activity-read-more" id="activity-read-more-12317"><a href="https://www.catswannabecats.com/activity/p/12317/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">133887645d25232ddacd6f359ae8781c</guid>
				<title>Campbell Timm posted an update: 05, 95% CI 0.91 to 1.22, 3800 patients, 9 studies), ocular [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/4216/</link>
				<pubDate>Sat, 31 May 2025 12:21:52 -0400</pubDate>

									<content:encoded><![CDATA[<p>05, 95% CI 0.91 to 1.22, 3800 patients, 9 studies), ocular hyperaemia (RR 1.31, 95% CI 0.96 to 1.78, 2268 patients, 5 studies), total ocular adverse events (RR 1.03, 95% CI 0.88 to 1.20, 1906 patients, 5 studies) or tear break-up time (mean difference 0.89, 95% CI -0.03 to 1.81, 130 patients, 3 studies). Diverse reporting on safety measures made&hellip;<span class="activity-read-more" id="activity-read-more-4216"><a href="https://www.catswannabecats.com/activity/p/4216/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">421c89fc604062bd7c23170c7564fc9f</guid>
				<title>Campbell Timm became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/4123/</link>
				<pubDate>Sat, 31 May 2025 12:11:17 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>